These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 22644947)
1. Physicochemical characterization of a prodrug of a radionuclide decorporation agent for oral delivery. Sueda K; Sadgrove MP; Fitzsimmons JM; Jay M J Pharm Sci; 2012 Aug; 101(8):2844-53. PubMed ID: 22644947 [TBL] [Abstract][Full Text] [Related]
2. Orally administered DTPA penta-ethyl ester for the decorporation of inhaled (241)Am. Sueda K; Sadgrove MP; Huckle JE; Leed MG; Weber WM; Doyle-Eisele M; Guilmette RA; Jay M J Pharm Sci; 2014 May; 103(5):1563-71. PubMed ID: 24619514 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and Physicochemical Characterization of a Diethyl Ester Prodrug of DTPA and Its Investigation as an Oral Decorporation Agent in Rats. Huckle JE; Sadgrove MP; Leed MG; Yang YT; Mumper RJ; Semelka RC; Jay M AAPS J; 2016 Jul; 18(4):972-80. PubMed ID: 27106838 [TBL] [Abstract][Full Text] [Related]
4. Solid dispersions of the penta-ethyl ester prodrug of diethylenetriaminepentaacetic acid (DTPA): formulation design and optimization studies. Yang YT; Di Pasqua AJ; Zhang Y; Sueda K; Jay M Pharm Dev Technol; 2014 Nov; 19(7):806-12. PubMed ID: 24047113 [TBL] [Abstract][Full Text] [Related]
5. Orally administered DTPA di-ethyl ester for decorporation of (241)Am in dogs: Assessment of safety and efficacy in an inhalation-contamination model. Huckle JE; Sadgrove MP; Pacyniak E; Leed MG; Weber WM; Doyle-Eisele M; Guilmette RA; Agha BJ; Susick RL; Mumper RJ; Jay M Int J Radiat Biol; 2015 Jul; 91(7):568-75. PubMed ID: 25912343 [TBL] [Abstract][Full Text] [Related]
6. Preparation of alginate beads containing a prodrug of diethylenetriaminepentaacetic acid. Yang YT; Di Pasqua AJ; He W; Tsai T; Sueda K; Zhang Y; Jay M Carbohydr Polym; 2013 Feb; 92(2):1915-20. PubMed ID: 23399237 [TBL] [Abstract][Full Text] [Related]
7. Nonaqueous gel for the transdermal delivery of a DTPA penta-ethyl ester prodrug. Zhang Y; Sadgrove MP; Sueda K; Yang YT; Pacyniak EK; Kagel JR; Braun BA; Zamboni WC; Mumper RJ; Jay M AAPS J; 2013 Apr; 15(2):523-32. PubMed ID: 23389812 [TBL] [Abstract][Full Text] [Related]
8. Decorporation of systemically distributed americium by a novel orally administered diethylenetriaminepentaacetic acid (DTPA) formulation in beagle dogs. Wilson JP; Cobb RR; Dungan NW; Matthews LL; Eppler B; Aiello KV; Curtis S; Boger T; Guilmette RA; Weber W; Doyle-Eisele M; Talton JD Health Phys; 2015 Mar; 108(3):308-18. PubMed ID: 25627942 [TBL] [Abstract][Full Text] [Related]
9. Radionuclide decorporation: matching the biokinetics of actinides by transdermal delivery of pro-chelators. Zhang Y; Sadgrove MP; Mumper RJ; Jay M AAPS J; 2013 Oct; 15(4):1180-8. PubMed ID: 23990504 [TBL] [Abstract][Full Text] [Related]
10. Decorporation of Pu/Am Actinides by Chelation Therapy: New Arguments in Favor of an Intracellular Component of DTPA Action. Grémy O; Laurent D; Coudert S; Griffiths NM; Miccoli L Radiat Res; 2016 Jun; 185(6):568-79. PubMed ID: 27195610 [TBL] [Abstract][Full Text] [Related]
11. Structure of a single model to describe plutonium and americium decorporation by DTPA treatments. Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Fattal E; Benech H; Deverre JR; Poncy JL Health Phys; 2010 Oct; 99(4):553-9. PubMed ID: 20838098 [TBL] [Abstract][Full Text] [Related]
12. Treatment of human contamination with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective? Taylor DM; Hodgson SA; Stradling N Radiat Prot Dosimetry; 2007; 127(1-4):469-71. PubMed ID: 17556346 [TBL] [Abstract][Full Text] [Related]
13. Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist. Beaumont K; Webster R; Gardner I; Dack K Curr Drug Metab; 2003 Dec; 4(6):461-85. PubMed ID: 14683475 [TBL] [Abstract][Full Text] [Related]
14. Biotransformation Capacity of Carboxylesterase in Skin and Keratinocytes for the Penta-Ethyl Ester Prodrug of DTPA. Fu J; Sadgrove M; Marson L; Jay M Drug Metab Dispos; 2016 Aug; 44(8):1313-8. PubMed ID: 27130352 [TBL] [Abstract][Full Text] [Related]
15. The physicochemical properties, in vitro metabolism and pharmacokinetics of a novel ester prodrug of EXP3174. Yan YD; Kim HK; Seo KH; Lee WS; Lee GS; Woo JS; Yong CS; Choi HG Mol Pharm; 2010 Dec; 7(6):2132-40. PubMed ID: 20849146 [TBL] [Abstract][Full Text] [Related]
16. Modulating lipophilicity of rohitukine via prodrug approach: Preparation, characterization, and in vitro enzymatic hydrolysis in biorelevant media. Kumar V; Bharate SS; Vishwakarma RA Eur J Pharm Sci; 2016 Sep; 92():203-11. PubMed ID: 27422078 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and Evaluation as Prodrugs of Hydrophilic Carbamate Ester Analogues of Resveratrol. Azzolini M; Mattarei A; La Spina M; Marotta E; Zoratti M; Paradisi C; Biasutto L Mol Pharm; 2015 Sep; 12(9):3441-54. PubMed ID: 26252229 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of orally administered amphipathic polyaminocarboxylic acid chelators for the removal of plutonium and americium: comparison with injected Zn-DTPA in the rat. Miller SC; Liu G; Bruenger FW; Lloyd RD Radiat Prot Dosimetry; 2006; 118(4):412-20. PubMed ID: 16332916 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate. Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406 [TBL] [Abstract][Full Text] [Related]
20. Species-dependent chelation of (241)Am by DTPA Di-ethyl ester. Huckle JE; Sadgrove MP; Mumper RJ; Jay M Health Phys; 2015 Apr; 108(4):443-50. PubMed ID: 25706138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]